The MAP2K1 mutations in exons 2 and 3 modify the αA helix and β3‐αC loop of MEK1, while BRAF mutations in exons 12 and 15 affect the β3‐αC loop and activation segment of BRAF in childhood LCH. This evidence concerns the gene MAP2K1 and Langerhans cell histiocytosis.